N6-methyladenosine in macrophage function: a novel target for metabolic diseases
Authors:
- 29 December 2022
- journal article
- review article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 34 (2) , 66-84
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- RNA helicase DDX5 participates in oxLDL-induced macrophage scavenger receptor 1 expression by suppressing mRNA degradationExperimental Cell Research, 2018
- METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A ModificationCell Stem Cell, 2018
- Dynamic m6A modification regulates local translation of mRNA in axonsNucleic Acids Research, 2017
- The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cellsNature Medicine, 2017
- m6A modulates haematopoietic stem and progenitor cell specificationNature, 2017
- Fat mass and obesity-associated protein attenuates lipid accumulation in macrophage foam cells and alleviates atherosclerosis in apolipoprotein E-deficient miceJournal Of Hypertension, 2017
- Structural Basis for Cooperative Function of Mettl3 and Mettl14 MethyltransferasesMolecular Cell, 2016
- Pharmacological Inhibition of FTOPLOS ONE, 2015
- N6-methyladenosine marks primary microRNAs for processingNature, 2015
- Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5Nucleic Acids Research, 2014